Clinical Trial Update: Safety and Efficacy of Ranibizumab in Diabetic Macular Edema [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ranibizumab for Diabetic Macular Edema was terminated; results assessing safety and efficacy were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Visual Impairment Due to Diabetic Macular Edema | Phase 3 | Status: TERMINATED | Results posted: 2012-08-17